Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Neutral
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
N/ATelephone
61.8.6478.7816
Address
1257 Hay Street West Perth, Western Australia (WA) 6005
Description
Artrya Ltd. develops the Salix suite of products to address coronary artery disease (CAD). It uses artificial intelligence (AI) to improve the detection and management of coronary artery disease. The company was founded by John Windsor Barrington and John Konstantopoulos on January 24, 2018 and is headquartered in West Perth, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.2 - 1.04
Trade Value (12mth)
AU$10,018.00
1 week
1.22%
1 month
-2.92%
YTD
33.87%
1 year
151.52%
All time high
1.75
EPS 3 yr Growth
241.00%
EBITDA Margin
N/A
Operating Cashflow
-$15m
Free Cash Flow Return
-61.10%
ROIC
-57.20%
Interest Coverage
-517.80
Quick Ratio
7.30
Shares on Issue (Fully Dilluted)
79m
HALO Sector
Technology
Next Company Report Date
28-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
20 February 25 |
Application for quotation of securities - AYA
×
Application for quotation of securities - AYA |
20 February 25 |
Cleansing Statement
×
Cleansing Statement |
17 February 25 |
Application for quotation of securities - AYA
×
Application for quotation of securities - AYA |
17 February 25 |
Cleansing Statement
×
Cleansing Statement |
14 February 25 |
Successful A$15m Placement
×
Successful A$15m Placement |
14 February 25 |
Proposed issue of securities - AYA
×
Proposed issue of securities - AYA |
14 February 25 |
Investor Presentation
×
Investor Presentation |
12 February 25 |
Trading Halt
×
Trading Halt |
12 February 25 |
AYA Secures Multi-Year Contract with Sonic Healthcare
×
AYA Secures Multi-Year Contract with Sonic Healthcare |
07 February 25 |
Notification of cessation of securities - AYA
×
Notification of cessation of securities - AYA |
29 January 25 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
16 January 25 |
Response to ASX Price Query
×
Response to ASX Price Query |
08 January 25 |
Notification regarding unquoted securities - AYA
×
Notification regarding unquoted securities - AYA |
23 December 24 |
Notification of cessation of securities - AYA
×
Notification of cessation of securities - AYA |
19 December 24 |
Issue of Unquoted Securities
×
Issue of Unquoted Securities |
19 December 24 |
AYA
×
AYA |
19 December 24 |
Notification regarding unquoted securities - AYA
×
Notification regarding unquoted securities - AYA |
12 December 24 |
Application for quotation of securities - AYA
×
Application for quotation of securities - AYA |
12 December 24 |
Cleansing Notice
×
Cleansing Notice |
28 November 24 |
2024 AGM Chair Address and CEO Presentation
×
2024 AGM Chair Address and CEO Presentation |
28 November 24 |
Results of Meeting
×
Results of Meeting |
27 November 24 |
Annual General Meeting Link
×
Annual General Meeting Link |
25 November 24 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
21 November 24 |
Change in substantial holding
×
Change in substantial holding |
19 November 24 |
Completion of Placement and Cleansing Notice
×
Completion of Placement and Cleansing Notice |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.